Treatment of COVID-19 Using Fluvoxamine Maleate
— Value Proposition: Novel method for treating short- and long-term symptoms of COVID-19 using a selective serotonin reuptake inhibitor (SSRI) and a sigma-1 receptor (S1R) agonist.
Technology Description
Researchers at Washington University in St. Louis have developed a novel method for treating …
